California based start-up developing whole-body mitochondrial transfusion technology to address Alzheimer's, Parkinson's, heart disease, sarcopenia, and other diseases of aging.

The bioreactor grows ‘young” mitochondria in large quantities, then wraps them in a special coating, with receptors to target specific organs. The goal is to produce bioreactor-grown mitochondria on an industrial scale, a “tool kit” of many different types of mitochondria that can be used by clinicians to regenerate different organs, sufficient to supplement every human being over the age of 55 and reduce severity of a wide array of diseases.